Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.
about
Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-AnalysisCan serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literatureEmerging trends in hepatocellular carcinoma incidence and mortality.Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration.Natural history of liver imaging reporting and data system category 4 nodules in MRI.Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma markerTaccaoside induces apoptosis in hepatocellular carcinoma cell lines.MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6.Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0TMolecular bioluminescence imaging as a noninvasive tool for monitoring tumor growth and therapeutic response to MRI-guided laser ablation in a rat model of hepatocellular carcinoma.Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 yearsCombined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.Role functioning is associated with survival in patients with hepatocellular carcinoma.The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.Prognostic significance of parameters from pretreatment (18)F-FDG PET in hepatocellular carcinoma: a meta-analysis.Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer.Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United StatesFive-Year Survival is Not a Useful Measure for Cancer Control in the Population: an Analysis Based on UK DataSocioeconomic factors affect disparities in access to liver transplant for hepatocellular cancerSocioeconomic status and hepatocellular carcinoma in the United States.Repeated Radiofrequency Ablation Combined With Ablated Lesion Elimination and Transarterial Chemoembolization Improves the Outcome of Solitary Huge Hepatocellular Carcinomas 10 m or LargerEpidemiology and surveillance of hepatocellular carcinoma.Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan.Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study.Japan's Successful Model of Nationwide Hepatocellular Carcinoma Surveillance Highlighting the Urgent Need for Global Surveillance.Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 PatientsMeta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States.Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case-Control Study.β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferationPotential of Radiofrequency Ablation in Combination with Immunotherapy in the Treatment of Hepatocellular Carcinoma.Systematic analyses and comprehensive field synopsis of genetic association studies in hepatocellular carcinomaComparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinomaFeatures of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic WhitesThe clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.
P2860
Q26769591-F7A0ACF9-FAE4-4E4E-BA43-5ED48BA4A040Q27023427-CB6BE940-3B55-458E-A855-213291F18886Q27334932-0B89E2B7-192B-47A0-84C4-0AED89FA62F7Q30359582-E2D019DF-4F1B-4FF3-8504-ECF03ADB78CDQ31090559-C9AB51F5-324D-44F6-8AA6-EA08B1076E88Q31113966-BC03C845-28CC-4FA3-838C-C9C0E348B7A3Q32186083-876D8993-866E-41BC-B6AF-8B6CE4BD63EFQ33744249-CDEA3234-F070-4892-AF49-D87EC81AA02AQ33960747-C1BC76B8-4459-4279-9DB0-4B2F82DABC59Q34015608-77854C4E-4837-43E9-8B80-039D57FE4F96Q34521354-9ADCB02A-149C-4E29-94A9-7621992F6754Q34851700-363786A3-937E-471D-8507-0B7669669A10Q35047746-089831A1-8A41-4B4B-9FB4-B40FB78FA94BQ35231826-909A3987-E774-4D90-9936-5525BA2E4575Q35424206-EBD93B0D-0582-480D-A65E-D7FA7FF00F18Q35738710-AAAD46BF-ACC8-40DC-8C0D-81FE00EE43F1Q35875277-27581B55-EB2C-475B-96A0-F4A6A394743AQ35910220-6BCB204F-BF44-4D02-9A69-C5DF0D67E87AQ36109796-D8AC1D2E-20E6-417B-9F22-C7FCA17A9B17Q36140389-E0966D03-8EB8-42B7-A8D5-B3A82FB24CE8Q36202481-191EF594-B494-4DB1-8B8C-19D36E35B38CQ36323584-779ED914-CCB9-4A52-9962-8C2192E77A38Q36486518-DCC29A3B-783C-4068-9668-B4A2533B508FQ36826126-AD7CADF4-8CD4-4866-B051-FAF0C9D0A2F8Q36838031-FA66EB3C-6B1C-4E9D-81BB-DB5EBAC68429Q37105532-90CA366A-7366-4B7F-A273-1281DC394A23Q37124700-AD00467B-4DC1-4945-B3AD-D1F9CC1BE8CDQ37133717-943E56CD-C9C2-4CFD-8C00-B585BE09F933Q37140675-E48C08C2-6F94-4510-A4ED-9EDDD8C517B5Q37176395-8AE1C17C-BD1B-4BF2-91E3-55EA5F757277Q37184472-C2BC4E19-F2D6-44B7-B0E1-C5E5ABEF7DD8Q37350320-62EF5AE1-FBD1-47DE-B565-11AA92FA4DDFQ37373904-E8A9B675-9E23-4397-BEDE-E3A3E9D9BDD9Q37417188-B278014E-8F86-4E8F-A51B-0DB4EE5E788EQ37545879-736AA19C-F91E-459D-BD37-B0328335621AQ37564545-53476D9B-9CF6-4E8F-8C30-E1EAC3512D60Q37606553-3CC7F1D1-A86E-45EB-8F99-799C16DEF730Q37648559-64E00E41-5A39-4F54-8615-63CFED5FC679Q37685733-67126E2B-B1B8-4E97-B3D8-A010DF27D580Q38217657-C7D86EF7-ECFC-4296-91E9-DEE085C0E203
P2860
Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocellular carcinoma confi ...... results registries, 1992-2008.
@en
Hepatocellular carcinoma confi ...... results registries, 1992-2008.
@nl
type
label
Hepatocellular carcinoma confi ...... results registries, 1992-2008.
@en
Hepatocellular carcinoma confi ...... results registries, 1992-2008.
@nl
prefLabel
Hepatocellular carcinoma confi ...... results registries, 1992-2008.
@en
Hepatocellular carcinoma confi ...... results registries, 1992-2008.
@nl
P2093
P2860
P356
P1433
P1476
Hepatocellular carcinoma confi ...... results registries, 1992-2008
@en
P2093
Katherine A McGlynn
Lois A Dickie
Sean F Altekruse
P2860
P304
P356
10.1002/HEP.24710
P407
P577
2012-02-01T00:00:00Z